Latest Refining News

Element 25 Limited reports a transformative quarter with a 142% resource increase at Butcherbird, a compelling $561 million NPV feasibility study, and a $268 million US Department of Energy grant to advance its Louisiana battery-grade manganese refinery.

Suvo Strategic Minerals delivered a robust December quarter with soaring profits and an extended supply deal, while advancing innovative low carbon cement projects in Australia and Indonesia.

Prodigy Gold's December 2024 quarterly report reveals significant high-grade gold intercepts at its Hyperion and Tregony projects, alongside progress on metallurgical testing and a new Mineral Lease application. The company maintains a solid cash position with no debt, positioning itself for an active 2025 exploration season.

New World Resources Limited has completed a significant reserve definition drilling program at its Antler Copper Project, alongside key permitting progress and accelerated funding discussions, setting the stage for a definitive feasibility study in 2025.

Kingsrose Mining, in alliance with BHP, reports promising high-grade copper and polymetallic discoveries in Norway and Finland, advancing one of Europe’s largest exploration programs.

Saturn Metals has engaged global heap leach engineering leader Kappes Cassiday & Associates to complete the Pre-Feasibility Study for its Apollo Hill Gold Project, marking a pivotal step in advancing the project’s development.

Tryptamine Therapeutics has reported successful Phase 1b results for its IV-infused psilocin candidate TRP-8803 and promising interim data for oral psilocybin TRP-8802 in IBS treatment, while securing $6 million in new funding to accelerate clinical development.

Great Divide Mining's latest LiDAR analysis at Devils Mountain reveals a wealth of previously unknown historical mine workings, significantly sharpening its gold exploration focus in southeast Queensland.

Resource Mining Corporation reports promising copper-gold exploration results at its Mpanda project in Tanzania, secures $1 million in loan funding, and gains an option to acquire a 70% stake in a Saudi Arabia joint venture.

NeuroScientific Biopharmaceuticals has initiated critical IND-enabling studies for its glaucoma drug candidate EmtinB, backed by a solid cash position of A$4.5 million as of December 2024. Preliminary melanin binding results are shaping the path toward first-in-human trials.

Southern Cross Gold Consolidated has reported exceptional high-grade gold intersections from deep drilling at its Christina prospect, confirming robust mineralization extending 350 metres below previous hits and expanding the Sunday Creek project's footprint.

Lanthanein Resources has completed initial drilling phases at its Lady Grey Project and secured a six-month extension on its farm-in agreement, positioning the company for a critical assessment of its gold exploration prospects.